Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium
Abstract: Variances in global access to drugs and treatment practices make it challenging to understand the benefit of contemporary therapies in patients with relapsed and refractory (R/R) mature T-cell and natural killer–cell lymphomas (MTCL and MNKCL). We conducted an international retrospective c...
Saved in:
Similar Items
-
Design and Fabrication of Remote Welding Equipment in a Hot-Cell
by: Soosung Kim, et al.
Published: (2013-01-01) -
The unseen carbon: Scope 3 emissions transform understanding of electricity generation in import-dependent nations
by: Seokju Kim, et al.
Published: (2025-02-01) -
Fresnel Prism on Hess Screen Test
by: Kyung Min Koh, et al.
Published: (2013-01-01) -
MiCML: a causal machine learning cloud platform for the analysis of treatment effects using microbiome profiles
by: Hyunwook Koh, et al.
Published: (2025-01-01) -
Looking to the past to see the future: mother–child future talk following memory sharing in three cultural communities
by: Jessie Bee Kim Koh, et al.
Published: (2025-01-01)